SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Biopharma Update on the Novel Coronavirus: December 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
December 15, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Photo Courtesy of Faze Medicines
Business
Biomolecular Condensates Gain More Funding as Faze Snags $81M for ALS & DM1
Cambridge-based Faze Medicines, the biotechnology company that develops therapeutics based on biomolecular condensates, announced today that it has raised $81 million in a Series A round of financing.
December 10, 2020
 · 
3 min read
 · 
Krystle Vermes
Policy
Biopharma Update on the Novel Coronavirus: December 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 8, 2020.
December 7, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 1, 2020.
December 1, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: November 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
November 23, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: November 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 17, 2020.
November 16, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
Inexpensive Nasal Spray Prevents COVID-19 Infection in Ferrets, Shows Promise for Human Trials
A multi-institutional research team has developed a nasal spray that effectively blocks absorption of the SARS-CoV-2 virus in ferrets with direct contact to infected animals.
November 6, 2020
 · 
3 min read
 · 
Brandon May
Drug Development
Research Roundup: Why Blood Clots in COVID-19 and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
November 5, 2020
 · 
5 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: November 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 3, 2020.
November 3, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: October 27
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 27, 2020.
October 27, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
December 12, 2024
 · 
7 min read
Press Releases
iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress
December 12, 2024
 · 
9 min read
Press Releases
Aptose Announces Publication of Preclinical Data in AACR Journal Demonstrating Tuspetinib’s Unique Mechanism of Action and Synthetic Lethality on AML Cells When Combined with Venetoclax
December 12, 2024
 · 
6 min read
Press Releases
Revolo Announces New Preclinical Data Supporting Subcutaneous ‘1104 for Atopic Dermatitis and Other Clinical Programs
December 12, 2024
 · 
4 min read
Press Releases
PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment
December 12, 2024
 · 
5 min read
Press Releases
Aditxt’s Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials
December 12, 2024
 · 
8 min read
Press Releases
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
 · 
5 min read
Press Releases
Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
December 11, 2024
 · 
4 min read
Press Releases
UPDATE - Remedy Plan Therapeutics Showcases Preclinical Data from First-In-Class NAMPT Inhibitor, RPT1G, Demonstrating Synergy with BCL-2 Family Inhibitors in AML at the 2024 ASH Annual Meeting
December 11, 2024
 · 
3 min read
Press Releases
Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting
December 10, 2024
 · 
6 min read
Press Releases
Ensem Therapeutics To Present Preclinical Data for Potential Best-in-Class Allosteric Pan-Mutant-Selective PI3Kα Inhibitor and Degrader at San Antonio Breast Cancer Symposium
December 10, 2024
 · 
3 min read
Press Releases
Ensem Therapeutics To Present Preclinical Data for Potential Best-in-Class Oral CDK2 Inhibitor at San Antonio Breast Cancer Symposium
December 10, 2024
 · 
3 min read
Press Releases
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
December 10, 2024
 · 
1 min read
Press Releases
Orna Therapeutics Presents Data Highlighting Novel panCAR™ Approach to Unlock LNP-Mediated RNA Delivery for B Cell Mediated Diseases at the 66th ASH Annual Meeting
December 10, 2024
 · 
2 min read
Press Releases
CatalYm Highlights Visugromab’s Potential to Treat Cachexia in Cancer Patients at International SCWD Conference
December 10, 2024
 · 
4 min read
Press Releases
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
December 10, 2024
 · 
6 min read
Press Releases
Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting
December 9, 2024
 · 
12 min read
Press Releases
Circle Pharma Presents Promising Preclinical Data on First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor CID-078 at the San Antonio Breast Cancer Symposium 2024
December 9, 2024
 · 
2 min read
Press Releases
Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
December 9, 2024
 · 
3 min read
Press Releases
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
December 9, 2024
 · 
6 min read
Load More